BN · rank #14 · 2026-10-21
EXENS
PARIS · EUR · $3.27B (USD)
The exact numbers the algorithm saw.
| Composite score Z-score blend of the factors below; drives the rank. | -0.35 |
|---|---|
| Forward revenue growth Consensus forward revenue growth. | +13.2% |
| Forward net margin Consensus forward net margin. | +6.6% |
| Net margin TTM Trailing twelve month net margin. | +6.0% |
| Margin expansion Forward minus trailing net margin (percentage points). | +0.6% |
| Forward PEG Forward P/E to growth. Below 1 is cheap for the growth. | — |
| Debt / FCF Net debt relative to free cash flow. Lower is safer. | 2.58× |
| Analyst upside Spread between the consensus 12m target and the current price. | +21.3% |
| Last EPS surprise Most recent reported EPS versus consensus. | — |
| Market cap (USD) | $3.27B |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Exosens manufactures high-performance image-intensifier tubes, thermal and cooled-infrared cameras, and nuclear instrumentation for defense, drone, and surveillance applications.
Rationale
Exosens reinforces the bottleneck-solver thesis as the only sizeable ITAR-free supplier delivering 5G image-intensifier performance to NATO defense markets, supported by tripling/doubling manufacturing expansion and raised FY2026 guidance.
Material risks
- 1Major defense customers or prime contractors developing in-house sensor capabilities or dual-sourcing night-vision components would disconfirm Exosens's bottleneck moat.
- 2Execution missteps or qualification delays in scaling European thermal and cooled-infrared camera capacity throughout 2026 could disrupt delivery timelines and growth targets.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 2 of 3 voted to proceed.